박사

칼슘 감지 수용체의 상호작용 연구와 새로운 약물 개발에의 응용

노효진 2015년
논문상세정보
' 칼슘 감지 수용체의 상호작용 연구와 새로운 약물 개발에의 응용' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • aeuqorin-based assay
  • bioluminescence resonance energy transfer
  • g-protein coupled receptor
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
31 0

0.0%

' 칼슘 감지 수용체의 상호작용 연구와 새로운 약물 개발에의 응용' 의 참고문헌

  • Zhu, W. Z., K. Chakir., S. Zhang., D. Yang., C. Lavoie., M. Bouvier.,T. E. Hebert., E. G. Lakatta., H. Cheng. and R. P. Xiao. (2005)Heterodimerization of beta1- and beta2-adrenergic receptor subtypesoptimizes beta-adrenergic modulation of cardiac contractility. CircRes 97(3): 244-51.
  • Yarova, P. L., A. L. Stewart., V. Sathish., R. D. Britt Jr., M. A.Thompson., A. P. P Lowe., M. Freeman., B. Aravamudan., H. Kita.,S. C. Brennan., M. Schepelmann., T. Davies., S. Yung., Z. Cholisoh.,E. J. Kidd., W. R. Ford., K. J. Broadley., K. Rietdorf., W. Chang., M.E. Bin Khayat., D. T. Ward., C. J. Corrigan., J. P. T Ward., P. J.Kemp., C. M. Pabelick., Y. S. Prakash. and D. Riccardi.(2015)Calcium-sensing receptor antagonists abrogate airwayhyperresponsiveness and inflammation in allergic asthma. Sci TranslMed 7(284): 284ra60.
  • Yang, W., Y. Wang., J. Y. Roberge., Z. Ma., Y. Liu., R. MichaelLawrence., D. P. Rotella., R. Seethala., J. H. Feyen. and J. K.Dickson. (2005) Discovery and structure-activity relationships of2-benzylpyrrolidine-substituted aryloxypropanols as calcium-sensingreceptor antagonists. Bioorg Med Chem Lett 15(4): 1225-8.
  • Xiao, X., P. Wang. and K. C. Chou. (2009) GPCR-CA: A cellularautomaton image approach for predicting G-protein-coupled receptorfunctional classes. J Comput Chem 30(9): 1414-23.
  • Wang, L., M. Million., J. Rivier., C. Rivier., N. Craft., M. P.Stenzel-Poore. and Y. Tache. (2011) CRF receptor antagonistastressin-B reverses and prevents alopecia in CRF over-expressingmice. PLoS One 6(2): e16377.
  • Vilardaga, J. P., V. O. Nikolaev., K. Lorenz., S. Ferrandon., Z.Zhuang. and M. J. Lohse. (2008) Conformational cross-talk betweenalpha2A-adrenergic and mu-opioid receptors controls cell signaling.Nat Chem Biol 4(2): 126-31.
  • Ungrin, M. D., L. M. Sinqh., R. Stocco., D. E. Sas. and M.Abramovitz. (1999) An automated aequorin luminescence-basedfunctional calcium assay for G-protein-coupled receptors. AnalBiochem 272(1): 34-42.
  • Tamayama, T., K. Maemura., K. Kanbara., H. Hayasaki., Y.Yabumoto., M. Yuasa. and M. Watanabe. (2005) Expression ofGABA(A and GABA(B receptors in rat growth plate chondrocytes:activation of the GABA receptors promotes proliferation of mousechondrogenic ATDC5 cells. Mol Cell Biochem 273(1-2): 117-26.
  • Stenzel-Poore, M. P., K. A. Heldwein., P. Stenzel., S. Lee. and W. W.Vale. (1992) Characterization of the genomic corticotropin-releasingfactor (CRF) gene from Xenopus laevis: two members of the CRFfamily exist in amphibians. Mol Endocrinol 6(10): 1716-24.
  • Steinhoff, M. and T. Biro. (2009) A TR(I)P to pruritus research: roleof TRPV3 in inflammation and itch. J Invest Dermatol 129(3): 531-5.
  • Steinhoff, M. S., B. V. Mentzer., P. Geppetti., C. Pothoulakis. and N.W. Bunnett. (2014) Tachykinins and their receptors: contributions tophysiological control and the mechanisms of disease. Physio Rev94(1): 265-301.
  • Spina, M., E. Merlo-Pich., R. K. Chan., A. M. Basso., J. Rivier., W.Vale. and G. F. Koob. (1996) Appetite-suppressing effects ofurocortin, a CRF-related neuropeptide. Science 273(5281): 1561-4.
  • So, C. H., V. Verma., B. F. O'Dowd. and S. R. George. (2007)Desensitization of the dopamine D1 and D2 receptor hetero-oligomermediated calcium signal by agonist occupancy of either receptor. MolPharmacol 72(2): 450-62.
  • Siebenhaar, F., A. A. Sharov., E. M. Peters., T. Y. Sharova., W.Syska., A. N. Mardaryev., P. Freyschmidt-Paul., J. P. Sundberg., M.Maurer. and V. A. Botchkarev. (2007) Substance p as animmunomodulatory neuropeptide in a mouse model for autoimmunehair loss(alopecia areata). J Invest Dermatol 127(6): 1489-97.
  • Sealfon, S. C. and J. Gonzalez-Maeso. (2008) Receptor pair forschizophrenia. Pediatr Res 64(1): 1.
  • Russell, F. D., D. Meyers., A. J. Galbraith., N. Bett., I. Toth., P.Kearns. and P. Molenaar. (2003) Elevated plasma levels of humanurotensin-II immunoreactivity in congestive heart failure. Am JPhysiol Heart Circ Physiol 285(4): H1576-81.
  • Roy-Byrne, P. P., T. W. Uhde., R. M. Post., W. Gallucci., G. P.Chrousos. and P. W. Gold. (1986) The corticotropin-releasinghormone stimulation test in patients with panic disorder. Am JPsychiatry 143(7): 896-9.
  • Romano, C., W. L. Yang. and K. L. O'Malley. (1996) Metabotropicglutamate receptor 5 is a disulfide-linked dimer. J Biol Chem 271(45):28612-6.
  • Rocheville, M., D. C. Lange., U, Kumar., S. C. Patel., R. C. Patel.and Y. C. Patel. (2000) Receptors for dopamine and somatostatin:formation of hetero-oligomers with enhanced functional activity.Science 288(5463): 154-7.
  • Robitaille, M., I. Heroux., A. Baragli. and T. E. Hebert. (2009) Noveltools for use in bioluminescence resonance energy transfer (BRET)assays. Methods Mol Biol 574: 215-34.
  • Riccardi, D., J. Park., W. S. Lee., G. Gamba., E. M. Brown. and S. C.Hebert. (1995) Cloning and functional expression of a rat kidneyextracellular calcium/polyvalent cation-sensing receptor. Proc NatlAcad Sci U S A 92(1): 131-5.
  • Rashid, A. J., C. H. So., M. M. Kong., T. Furtak., M. El-Ghundi., R.Cheng., B. F. O'Dowd. and S. R. George. (2007) D1-D2 dopaminereceptor heterooligomers with unique pharmacology are coupled torapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A104(2): 654-9.
  • Poul, E. L., S. Hisada., Y. Mizuguchi., V. J. Dupriez., E. Burgeon. andM. Detheux. (2002) Adaptation of aequorin functional assay to highthroughput screening. J Biomol Screen 7(1): 57-65.
  • Potts, J. T. (2005) Parathyroid hormone: past and present. JEndocrinol 187(3): 311-25.
  • Pfleger, K. D. and K. A. Eidne. (2006) Illuminating insights intoprotein-protein interactions using bioluminescence resonance energytransfer (BRET). Nat Methods 3(3): 165-74.
  • Pfeiffer. M., T. Koch., H. Schroder., M. Klutzny., S. Kirscht., H. J.Kreienkamp., V. Hollt. and S. Schulz. (2001) Homo- andheterodimerization of somatostatin receptor subtypes. Inactivation ofsst(3) receptor function by heterodimerization with sst(2A). J BiolChem 276(17): 14027-36.
  • Perrin, M. H., S. Sutton., D. L. Bain., W. T. Berggren., W. W. Vale.(1998) The first extracellular domain of corticotropin releasingfactor-R1 contains major binding determinants for urocortin andastressi. Endocrinology 139(2): 566-70.
  • Pavlovic, S., C. Liezmann., S. M. Blois., R. Joachim., J. Kruse., N.Romani., B. F. Klapp. and E. M. Peters. (2011) Substance p is a keymediator of stress-induced protection from allergic sensitization viamodified antigen presentation. J Immunol 186(2): 848-55.
  • Pausch, M. H. (1997) G-protein-coupled receptors in Saccharomycescerevisiae: high-throughput screening assays for drug discovery.Trends Biotechnol 15(12): 487-94.
  • Paglin, S. and J. D. Jamieson. (1982) Covalent crosslinking ofangiotensin II to its binding sites in rat adrenal membranes. ProcNatl Acad Sci U S A 79(12): 3739-43.
  • Owens, M. J. and C. B. Nemeroff. (1991) Physiology andpharmacology of corticotropin-releasing factor. Pharmacol Rev 43(4):425-73.
  • Orozco, A. S., X. Zhou. and S. G. Filler. (2000) Mechanisms of theproinflammatory response of endothelial cells to candida albicansinfection. Infect Immun 68(3): 1134-41.
  • Ohtaki, T., Y. Shintani., S. Honda., H. Matsumoto., A. Hori., K.Kanehashi., Y. Terao., S. Kumano., Y. Takatsu., Y. Masuda., Y.Ishibashi., T. Watanabe., M. Asada., T. Yamada., M. Suenaga., C.Kitada., S. Usuki., T. Kurokawa., H. Onda., O. Nishimura. and M.Fujino. (2001) Metastasis suppressor gene KiSS-1 encodes peptideligand of a G-protein-coupled receptor. Nature 411(6837): 613-7.
  • Neves, S. R., P. T. Ram. and R. Iyengar. (2002) G protein pathways.Science 296(5573): 1636-9.
  • Nemeth, E. F. and A. Scarpa. (1987) Rapid mobilization of cellularCa2+ in bovine parathyroid cells evoked by extracellular divalentcations. Evidence for a cell surface calcium receptor. J Biol Chem262(11): 5188-96.
  • Nemeroff, C. B., E. Widerlov., G. Bissette., H. Walleus., I. Karlsson.,K. Eklund., C. D. Kilts., P. T. Loosen. and W. Vale. (1984) Elevatedconcentrations of CSF corticotropin-releasing factor-likeimmunoreactivity in depressed patients. Science 226(4680): 1342-4.
  • Mosekilde, L., C. H. Sogaard., J. E. McOsker. and T. J. Wronski.(1994) PTH has a more pronounced effect on vertebral bone massand biomechanical competence than antiresorptive agents (estrogenand bisphosphonate)--assessed in sexually mature, ovariectomizedrats. Bone 15(4): 401-8.
  • Michel, B. (2001) Oligomerization of G-protein-coupled transmitterreceptors. Nature Reviews Neuroscience 2(4): 274-86.
  • Mellado, M., J. M. Rodriguez-Frade., A. J. Vila-Coro., A. M. de Ana.an C. Martinez-A. (1999) Chemokine control of HIV-1 infection.Nature 400(6746): 723-4.
  • Mcconnell, H. M., J. C. Owicki., J. W. Parce., D. L. Miller., G. T.Baxter., H. G. Wada. and S. Pitchford. (1992) The cytosensormicrophysiometer: biological applications of silicon technology. Science257(5078): 1906-12.
  • McGraw, D. W., K. A. Mihlbachler., M. R. Schwarb., F. F. Rahman.,K. M. Small., K. F. Almoosa. and S. B. Liggett. (2006) Airway smoothmuscle prostaglandin-EP1 receptors directly modulatebeta2-adrenergic receptors within a unique heterodimeric complex. JClin Invest 116(5): 1400-9.
  • Matsushita, M., M. Shichiri., T. Imai., M. Iwashina., H. Tanaka., N.Takasu. and Y. Hirata. (2001) Co-expression of urotensin II and itsreceptor (GPR14) in human cardiovascular and renal tissues. JHypertens 19(12): 2185-90.
  • Marinissen, M. J. and J. S. Gutkind. (2001) G-protein-coupled receptorsand signaling networks: emerging paradigms. Trends Pharmacol Sci22(7): 368-76.
  • Marie, P. J. (2010) The calcium-sensing receptor in bone cells: apotential therapeutic target in osteoporosis. Bone 46(3): 571-6.
  • Margeta-Mitrovic, M., Y. N. Jan. and L. Y. Jan. (2001) Function ofGB1 and GB2 subunits in G protein coupling of GABA(B receptors.Proc Natl Acad Sci U S A 98(25): 14649-54.
  • Maguire, J. J., A. P. Davenport. and R. E. Kuc. (2000)Orphan-receptor ligand human urotensin II: receptor localization inhuman tissues and comparison of vasoconstrictor responses withendothelin-1. Br J Pharmacol 131(3): 441-6.
  • Liu, N., L. H. Wang., L. L. Guo., G. Q. Wang., X. P. Zhou., Y.Jiang., J. Shang., K. Murao., J. W. Chen., W. Q. Fu. and G. X.Zhang. (2013) Chronic restraint stress inhibits hair growth viasubstance p mediated by reactive oxygen species in mice. PloS One8(4): 1-11.
  • Lin, L., W. Jiang., W. H. Ding., Y. G. Zhang., Y. F. Qi., W. J. Yuan.and C. S. Tang. (2004) Urotensin-II activates L-arginine/nitric oxidepathway in isolated rat aortic adventitia. Peptides 25(11): 1977-84.
  • Lee, S. P., Z. Xie., G. Varghese., T. Nguyen., B. F. O'Dowd. and S.R. George. (2000) Oligomerization of dopamine and serotoninreceptors. Neuropsychopharmacology 23: 32-40.
  • Lee, M. W., C. H. Oh., J. Kwon., C. H. Song. and C. H. Lee. (2005)The Studies on the Factors Related to Normal Hair Growth DuringPostnatal Growth Periods in C57BL/6N, Hairless and Alopecia AreataMice Model. Korea J Phys Anthropol 18(1): 13-27.
  • Lee, B., B. J. Doranz., S. Rana., Y. Yi., M. Mellado., J. M. Frade., C.Martinez-A., S. J. O'Brien., M. Dean., R. G. Collman. and R. W.Doms. (1998) Influence of the CCR2-V64I polymorphism on humanimmunodeficiency virus type 1 coreceptor activity and on chemokinereceptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol 72(9):7450-8.
  • Lee D. K., T. Nguyen., G. P. O'Neill., R. Cheng., Y. Liu., A. D.Howard., N. Coulombe., C. P. Tan., A. T. Tang-Nguyen., S. R.George. and B. F. O'Dowd BF. (1999) Discovery of a receptorrelated to the galanin receptors. FEBS Lett 446(1): 103-7.
  • Kumar, U. and M. Grant. (2010) Somatostatin and somatostatinreceptors. Results Probl Cell Differ 50: 137-84.
  • Kotani, M., M. Detheux., A. Vandenbogaerde., D. Communi., J. M.Vanderwinden., E. Le Poul., S. Brezillon., R. Tyldesley., N.Suarez-Huerta., F. Vandeput., C. Blanpain., S. N. Schiffmann., G.Vassart. and M. Parmentier. (2001) The metastasis suppressor geneKiSS-1 encodes kisspeptins, the natural ligands of the orphan Gprotein-coupled receptor GPR54. J Biol Chem 276(37): 34631-6.
  • Kocan, M., H. B. See., R. M. Seeber., K. A. Eidne. and K. D. Pfleger.(2008) Demonstration of improvements to the bioluminescenceresonance energy transfer (BRET) technology for the monitoring ofG protein-coupled receptors in live cells. J Biomol Screen 13(9):888-98.
  • Kocan, M. and K. D. Pfleger. (2009) Detection of GPCR/beta-arrestininteractions in live cells using bioluminescence resonance energytransfer technology. Methods Mol Biol 552: 305-17.
  • Kenneth, A. J., B. Beth., T. A. Joe., C. A. Douglas., D. M. Margaret.,M. Dai., Wen-Jeng. Yao., J. Mary., G. Caryn., Ling-Yan. Huang., C.Tang., Q. Shen., S. A. John., M. Kelley., L. Thomas., S. E. Kelli., N.Dhanapalan., N. A. Stewart., B. A. Theresa A. and G. Christophe.(1998) GABAB receptors function as a heteromeric assembly of thesubunits GABABR1 and GABABR2. Nature 396(6712): 674-79.
  • Kendall, J. M. and M. N. Badminton. (1998) Aequorea victoriabioluminescence moves into an exciting new era. Trends Biotechnol16(5): 216-24.
  • Joshi, S. K., and P. Honore. (2006) Animal models of pain for drugdiscovery. Expert Opin Drug Discov 1(4): 323-34.
  • Jordan, B. A., I. Gomes., C. Rios., J. Filipovska. and L. A. Devi.(2003) Functional interactions between mu opioid and alpha2A-adrenergic receptors. Mol Pharmacol 64(6): 1317-24.
  • Jordan, B. A. and L. A. Devi. (1999) G-protein-coupled receptorheterodimerization modulates receptor function. Nature 399(6737):697-700.
  • Johnston. P. A. and P. A. Johnston. (2002) Cellular platforms forHTS: three case studies. Johnston. Drug Discov Today 7(6): 353-63.
  • Hebert, T. E. and M. Bouvier. (1998) Structural and functionalaspects of G protein-coupled receptor oligomerization. Biochem CellBiol 76(1): 1-11.
  • Hansen, J. L., J. T. Hansen., T. Speerschneider., C. Lyngs ., N.Erikstrup., E. S. Burstein., D. M. Weiner., T. Walther., N. Makita., T.Iiri., N. Merten., E. Kostenis. and S. P. Sheikh. (2009) Lack ofevidence for AT1R/B2R heterodimerization in COS-7, HEK293, andNIH3T3 cells: how common is the AT1R/B2R heterodimer?. J BiolChem 284(3): 1831-9.
  • Hall, M. P., J. Unch., B. F. Binkowski., M. P. Valley., B. L. Butler.,M. G. Wood., P. Otto., K. Zimmerman., G. Vidugiris., T. Machleidt.,M. B. Robers., H. A. Benink., C. T. Eggers., M. R. Slater., P. L.Meisenheimer., D. H. Klaubert., F. Fan., L. P. Encell. and K. V.Wood. (2012) Engineered luciferase reporter from a deep sea shrimputilizing a novel imidazopyrazinone substrate. ACS Chem Biol 7(11):1848-57.
  • Hahn, M. K. and M. J. Bannon. (1999) Stress-induced C-fosexpression in the rat locus coeruleus is dependent on neurokinin 1receptor activation. Neuroscience 94(4): 1183-8.
  • Guo, W., E. Urizar., M. Kralikova., J. C. Mobarec., L. Shi., M.Filizola. and J. A. Javitch. (2008) Dopamine D2 receptors form higherorder oligomers at physiological expression levels. EMBO J 27(17):2293-304.
  • Gudermann, T., F. Kalkbrenner. and G. Schultz. (1996) Diversity andselectivity of receptor-G protein interaction. Annu Rev PharmacolToxicol 36: 429-59.
  • Gonzalez-Maeso, J., R. L. Ang., T. Yuen., P. Chan., N. V. Weisstaub.,J. F. Lopez-Gimenez., M. Zhou., Y. Okawa., L. F. Callado., G.Milligan., J. A. Gingrich., M. Filizola., J. J. Meana. and S. C. Sealfon.(2008) Identification of a serotonin/glutamate receptor compleximplicated in psychosis. Nature 452(7183): 93-7.
  • George, S. R., T. Fan., Z. Xie., R. Tse., V. Tam., G. Varghese. andB. F. O'Dowd. (2000) Oligomerization of mu- and delta-opioidreceptors. Generation of novel functional properties. J Biol Chem275(34): 26128-35.
  • Gama, L., S. G. Wilt. and G. E. Breitwieser. (2001)Heterodimerization of calcium sensing receptors with metabotropicglutamate receptors in neurons. J Biol Chem 276(42): 39053-9.
  • Galvez, T., B. Duthey., J. Kniazeff., J. Blahos., G. Rovelli., B.Bettler., L. Prezeau. and J. P. Pin. (2001) Allosteric interactionsbetween GB1 and GB2 subunits are required for optimal GABABreceptor function. EMBO J 20(9): 2152-9.
  • Fuxe, K., S. Ferre., M. Canals., M. Torvinen., A. Terasmaa., D.Marcellino., S. R. Goldberg., W. Staines., K. X. Jacobsen., C. Lluis.,A. S. Woods., L. F. Agnati. and R. Franco. (2005) Adenosine A2Aand dopamine D2 heteromeric receptor complexes and theirfunction. J Mol Neurosci 26(2-3): 209-20.
  • Funes, S., J. A. Hedrick., G. Vassileva., L. Markowitz., S.Abbondanzo., A. Golovko., S. Yang., F. J. Monsma. and E. L.Gustafson. (2003) The KiSS-1 receptor GPR54 is essential for thedevelopment of the murine reproductive system. Biochem BiophysRes Commun 312(4): 1357-63.
  • Fraser, C. M. and J C. Venter. (1982) The size of the mammalianlung beta 2-adrenergic receptor as determined by target size analysisand immunoaffinity chromatography. Biochem Biophys Res Commun109(1): 21-9.
  • Fan, T., G. Varghese., T. Nguyen., R. Tse., B. F. O'Dowd. and S. R.George. (2005) A role for the distal carboxyl tails in generating thenovel pharmacology and G protein activation profile of mu and deltaopioid receptor hetero-oligomers. J Biol Chem 280(46): 38478-88.
  • Fan, G. F., K. Ray., X. M. Zhao., P. K. Goldsmith. and A. M.Spiegel. (1998) Mutational analysis of the cysteines in theextracellular domain of the human Ca2+ receptor: effects on cellsurface expression, dimerization and signal transduction. FEBS Lett436(3): 353-6.
  • Ellgaard, L. and A. Helenius. (2003) Quality control in theendoplasmic reticulum. Nat Rev Mol Cell Biol 4(3): 181-91.
  • Eglen, R. M., R. Bosse. and T. Reisine. (2007) Emerging concepts ofguanine nucleotide-binding protein-coupled receptor (GPCR) functionand implications for high throughput screening. Assay Drug DevTechnol 5(3): 425-51.
  • Dragulescu-Andrasi, A., C. T. Chan., A. De., T. F. Massoud. and S.S. Gambhir. (2011) Bioluminescence resonance energy transfer(BRET) imaging of protein-protein interactions within deep tissues ofliving subjects. Proc Natl Acad Sci U S A 108(29): 12060-5.
  • Dhillo, W. S., O. B. Chaudhri., M. Patterson., E. L. Thompson., K. G.Murphy., M. K. Badman., B. M. McGowan., V. Amber., S. Patel., M.A. Ghatei. and S. R. Bloom. (2005) Kisspeptin-54 stimulates thehypothalamic-pituitary gonadal axis in human males. J Clin EndocrinolMetab 90(12): 6609-15.
  • De, A., P. Ray., A. M. Loening. and S. S. Gambhir. (2009) BRET3: ared-shifted bioluminescence resonance energy transfer (BRET)-basedintegrated platform for imaging protein-protein interactions fromsingle live cells and living animals. FASEB J 23(8): 2702-9.
  • De, A., A. M. Loening. and S. S. Gambhir. (2007) An improvedbioluminescence resonance energy transfer strategy for imagingintracellular events in single cells and living subjects. Cancer Res67(15): 7175-83.
  • Dalrymple, M. B., K. D. Pfleger. and K. A. Eidne. (2008) Gprotein-coupled receptor dimers: functional consequences, diseasestates and drug targets. Pharmacol Ther 118(3): 359-71.
  • Dacres, H., J. Wang., M. M. Dumancic. and S. C. Trowell. (2010)Experimental determination of the Forster distance for two commonlyused bioluminescent resonance energy transfer pairs. Anal Chem82(1): 432-5.
  • Cornea, A., J. A. Janovick., G. Maya-Nunez. and P. M. Conn. (2001)Gonadotropin-releasing hormone receptor microaggregation. Ratemonitored by fluorescence resonance energy transfer. J Biol Chem276(3): 2153-8.
  • Chunmin, D., M. F. Catalin., T. D. Matthew. and W. Guangyu.(2007) Regulation of G protein-coupled receptor export trafficking.Biochim Biophys Acta 1768(4): 853-70.
  • Chidiac, P., V. S. Markin. and E. M. Ross. (1999) Kinetic control ofguanine nucleotide binding to soluble Galpha(q). Biochem Pharmacol58(1): 39-48.
  • Cheng, Z., C. Tu., L. Rodriguez., T. H. Chen., M. M. Dvorak., M.Margeta., M. Gassmann., B. Bettler., D. Shoback. and W. Chang.(2007) Type B gamma-aminobutyric acid receptors modulate thefunction of the extracellular Ca2+-sensing receptor and celldifferentiation in murine growth plate chondrocytes. Endocrinology148(10): 4984-92.
  • Chang, W., C. Tu., Z. Cheng., L. Rodriguez., T. H. Chen., M.Gassmann., B. Bettler., M. Margeta., L. Y. Jan. and D. Shoback.(2007) Complex formation with the Type B gamma-aminobutyric acidreceptor affects the expression and signal transduction of theextracellular calcium-sensing receptor. Studies with HEK-293 cellsand neurons. J Biol Chem 282(34): 25030-40.
  • Carriba, P., G. Navarro., F. Ciruela., S. Ferre., V. Casado., L.Agnati., A. Cortes., J. Mallol., K. Fuxe., E. I. Canela., C. Lluis. and R.Franco. (2008) Detection of heteromerization of more than twoproteins by sequential BRET-FRET. Nat Methods 5(8): 727-33.
  • Brown, E. M., G. Gamba., D. Riccardi., M. Lombardi., R. Butters., O.Kifor., A. Sun., M. A. Hediger., J. Lytton. and S. C. Hebert. (1993)Cloning and characterization of an extracellular Ca(2+)-sensingreceptor from bovine parathyroid. Nature 366(6455): 575-80.
  • Blandini, F. (2003) Adenosine receptors and L-DOPA-induceddyskinesia in Parkinson's disease: potential targets for a newtherapeutic approach. Exp Neurol 184(2): 556-60.
  • Behan, D. P., S. C. Heinrichs., J. C. Troncoso., X. J. Liu., C. H.Kawas., N. Ling. and E. B. De Souza. (1995) Displacement ofcorticotropin releasing factor from its binding protein as a possibletreatment for Alzheimer's disease. Nature 378(6554): 284-7.
  • Barki-Harrington, L., L. M. Luttrell. and H. A. Rockman. (2003) Dualinhibition of beta-adrenergic and angiotensin II receptors by a singleantagonist: a functional role for receptor-receptor interaction in vivo.Circulation 108(13): 1611-8.
  • Barki-Harrington, L., A. L. Bookout., G. Wang., M. E. Lamb., L. M.Leeb-Lundberg. and Y. Daaka. (2003) Requirement for directcross-talk between B1 and B2 kinin receptors for the proliferation ofandrogen-insensitive prostate cancer PC3 cells. Biochem J 371(Pt 2):581-7.
  • Bai. M., S. Trivedi., O. Kifor., S. J. Quinn. and E. M. Brown. (1999)Intermolecular interactions between dimeric calcium-sensing receptormonomers are important for its normal function. Proc Natl Acad SciU S A 96(6): 2834-9.
  • Bai, M., S. Trivedi. and E. M. Brown. (1998) Dimerization of theextracellular calcium-sensing receptor (CaR) on the cell surface ofCaR-transfected HEK293 cells. J Biol Chem 273(36): 23605-10.
  • Ames, R. S., H. M. Sarau., J. K. Chambers., R. N. Willette., N. V.Aiyar., A. M. Romanic., C. S. Louden., J. J. Foley., C. F. Sauermelch.,R. W. Coatney., Z. Ao., J. Disa., S. D. Holmes., J. M. Stadel., J. D.Martin., W. S. Liu., G. I. Glover., S. Wilson., D. E. McNulty., C. E.Ellis., N. A. Elshourbagy., U. Shabon, J. J. Trill, D. W. Hay., E. H.Ohlstein., D. J. Bergsma. and S. A. Douglas. (1999) Humanurotensin-II is a potent vasoconstrictor and agonist for the orphanreceptor GPR14. Nature 401(6750): 282-6.
  • Aguilera, G. (2011) Regulation of the hypothalamic-pituitary-adrenalaxis by neuropeptides. Horm Mol Biol Clin Investig 7(2): 327-36.
  • Agnati, L. F. and K. Fuxe.(1984). New concepts on the structure ofthe neuronal networks: the miniaturization and hierarchicalorganization of the central nervous system.(Hypothesis). Biosci Rep4(2): 93-8.
  • AbdAlla, S., H. Lother., A. el Massiery. and U. Quitterer. (2001)Increased AT(1) receptor heterodimers in preeclampsia mediateenhanced angiotensin II responsiveness. Nat Med 7(9): 1003-9.
  • AbdAlla, S., H. Lother. and U. Quitterer. (2000) AT1-receptorheterodimers show enhanced G-protein activation and alteredreceptor sequestration. Nature 407(6800): 94-8.
  • AbdAlla, S., A. Abdel-Baset., H. Lother., A. el Massiery. and U.Quitterer. (2005) Mesangial AT1/B2 receptor heterodimers contributeto angiotensin II hyperresponsiveness in experimental hypertension. JMol Neurosci 26(2-3): 185-92.